Safety, Tolerability and Pharmacokinetics of Y-2 Sublingual Tablet

Not yet recruiting

Phase 1 Results N/A

Summary of Purpose

The primary objective is to evaluate the safety and tolerability of single ascending dose of Y-2 sublingual tablets in healthy male and female adult subjects. The secondary objective is to characterize the single-dose pharmacokinetics of Y-2 sublingual tablets in healthy male and female adult subjects.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 April 2018.

1 Apr 2018 21 Mar 2018 1 Aug 2018 1 Oct 2018 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts